NPPA notified regarding the fixation of the retail price of Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg + Metformin Hydrochloride IP 500 mg

Nov 10, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on November 07, 2024, notified regarding the fixation of the retail price of Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg + Metformin Hydrochloride IP 500 mg.

The following has been stated namely: -

• It has fixed the rate at Rs. 17.26/- for the Composition of each film-coated bilayered tablet containing: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg + Metformin Hydrochloride IP 500 mg.

[Notification no. - 19(4243)/2024/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT